Mostrar el registro sencillo del ítem

dc.contributor.authorDiaz L.
dc.contributor.authorDíaz-Herrera T.H.
dc.contributor.authorCoy-Barrera E.
dc.date.accessioned2025-01-15T20:49:03Z
dc.date.available2025-01-15T20:49:03Z
dc.date.issued2024
dc.identifier.otherhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85210677388&doi=10.3390%2fpharmaceutics16111381&partnerID=40&md5=3a3e545a2fdff5409574cf03acf9e47e
dc.identifier.urihttp://hdl.handle.net/10818/63279
dc.description.abstractBackground/Objectives: Phyllanthus species are renowned in traditional medicine for their diverse therapeutic properties, including potential anticancer activities. This study explored the antiproliferative potential of six Phyllanthus species by integrating chemical composition with bioactivity assays to identify key antiproliferative compounds. Methods: The integration of liquid chromatography–mass spectrometry (LC-MS)-based chemical composition data with antiproliferative activity against three cancer cell lines—PC-3 (prostate adenocarcinoma), SiHa (cervical carcinoma), and A549 (lung carcinoma)—as well as a normal mouse fibroblast line (L929) was performed by covariate analysis. These compounds were subsequently isolated and structurally characterized using spectroscopic methods. Results: Through covariate statistics, seven m/z features were found to be plausible active compounds, and after isolation, they were related to butyrolactone and arylnaphthalide lignans. Among the active isolates, an unreported compound, (+)-phyllanlathyrin 6, was discovered in the aerial part of Phyllanthus lathyroides. The isolated compounds exhibited moderate to good antiproliferative activity (IC50 < 20 µM) with selectivity to SiHa, validating the covariate-based identification approach. Conclusions: These findings highlight the potential of Phyllanthus species as sources of novel anticancer agents, with specific arylnaphthalide lignans showing promising cytotoxic effects that could be further developed into therapeutic leads. Additionally, this study underscores the value of combining advanced analytical techniques with bioactivity testing to uncover bioactive compounds from natural sources. The results contribute to the growing body of evidence supporting the therapeutic relevance of Phyllanthus species and provide a foundation for future drug development efforts targeting cancer treatment. © 2024 by the authors.en
dc.formatapplication/pdfes_CO
dc.language.isoenges_CO
dc.publisherPharmaceuticses_CO
dc.relation.ispartofseriesPharmaceutics vol. 16 n. 11
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.otherAntiproliferative Agents
dc.subject.otherBioactivity
dc.subject.otherCovariate Analysis
dc.subject.otherLignans
dc.subject.otherPhyllanthus
dc.titleChemical Composition and Bioactivity Dataset Integration to Identify Antiproliferative Compounds in Phyllanthus Plantsen
dc.typejournal articlees_CO
dc.type.hasVersionpublishedVersiones_CO
dc.rights.accessRightsopenAccesses_CO
dc.identifier.doi10.3390/pharmaceutics16111381


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 InternacionalExcepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional